Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 629-757-0 | CAS number: 1224966-15-7
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
![](https://echa.europa.eu/o/diss-blank-theme/images/factsheets/A-REACH/factsheet/print_toxicological-information.png)
Endpoint summary
Administrative data
Description of key information
Oral LD50 = 4000 mg/kg in rat; dermal LD50 > 2000 mg/kg bw in rat.
Key value for chemical safety assessment
Acute toxicity: via oral route
Link to relevant study records
- Endpoint:
- acute toxicity: oral
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Reliability:
- 2 (reliable with restrictions)
- Rationale for reliability incl. deficiencies:
- other: Old report, non-GLP. Limited detail reported.
- Reason / purpose for cross-reference:
- reference to same study
- Qualifier:
- equivalent or similar to guideline
- Guideline:
- OECD Guideline 401 (Acute Oral Toxicity)
- Deviations:
- yes
- Remarks:
- No body weight recording; No addtional group of the other sex was dosed.
- GLP compliance:
- no
- Remarks:
- Pre-GLP; signed authentication form present
- Test type:
- standard acute method
- Limit test:
- no
- Species:
- rat
- Strain:
- Sprague-Dawley
- Sex:
- male
- Details on test animals or test system and environmental conditions:
- TEST ANIMALS
- Source: Bantin and Kipman Ltd; caesarian-derived, outbread SD
- Age at study initiation:
- Weight at study initiation: 121-145 g
- Fasting period before study: 16 hrs
- Housing: groups of 6 animals in suspended plastic cages
- Diet (e.g. ad libitum): expanded autoclaved small animal diet (Spratt's Lab. Diet No. 1); ad lib
- Water (e.g. ad libitum): source not specified; ad lib
- Acclimation period: 1 week for range finder; 3 weeks for main study.
ENVIRONMENTAL CONDITIONS: not indicated - Route of administration:
- oral: gavage
- Vehicle:
- water
- Details on oral exposure:
- VEHICLE
- Amount of vehicle (if gavage): constant volume of 20 ml/kgBW
- Concentration in vehicle: dose between 1.0 to 8 g/kgBW, thus concentration between 50 - 400 g/L
- Justification for choice of vehicle: Leads to acceptable emulsion
- Lot/batch no. (if required): not indicated
- Purity: not indicated
MAXIMUM DOSE VOLUME APPLIED: constant volume of 20 ml/kgBW - Doses:
- Range finder: 1 , 2, 4, 6, 8 g/kgBW
Main study: 2.25, 2.92, 3.80, 4.94, 6.42 g/kgBW - No. of animals per sex per dose:
- Range finder: 2 animals/group
Main study: 6 animals/group - Control animals:
- no
- Details on study design:
- - Duration of observation period following administration: 14 days
- Frequency of observations and weighing: not indicated. No BW measured
- Necropsy of survivors performed: yes/no
- Other examinations performed: clinical signs, body weight,organ weights, histopathology, other: Clinical signs at least daily. Macroscopic post mortem examination. - Statistics:
- LD50 calculated according to Thompson WR (1947) Bact. Reviews 11, 115.
- Preliminary study:
- dose-range study with 5 dose levels: 1.0, 2.0, 4.0, 6.0 and 8.0 g/kgBW
At 1.0 and 2.0 g/kg no deaths occurred. At higher levels all animals died. (See table for further information) - Sex:
- male
- Dose descriptor:
- LD50
- Effect level:
- ca. 4 000 mg/kg bw
- 95% CL:
- 3 400 - 4 800
- Interpretation of results:
- Category 5 based on GHS criteria
- Remarks:
- Migrated information
- Conclusions:
- LD50 = 4 g/kgBW
- Executive summary:
The acute oral toxicity of Berolamine AA15 was investigated in male Sprague Dawley rats. The Median Lethal Dose and its 95% confidence limits were calculated to be 4.0 (3.4 -4.8) g/kg. As such this material may be classified as category 5 for acute toxicity hazard (GHS).
Reference
Endpoint conclusion
- Endpoint conclusion:
- adverse effect observed
- Dose descriptor:
- LD50
- Value:
- 4 000 mg/kg bw
- Quality of whole database:
- Old report, non-GLP, and limited detail reported. Study is in agreement with other available information.
Acute toxicity: via inhalation route
Endpoint conclusion
- Endpoint conclusion:
- no study available
Acute toxicity: via dermal route
Link to relevant study records
- Endpoint:
- acute toxicity: dermal
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- other: Berolamine 715. OECD guideline, GLP principles.
- Reason / purpose for cross-reference:
- reference to same study
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 402 (Acute Dermal Toxicity)
- GLP compliance:
- yes
- Remarks:
- Following GLP principles; statement SD & QA available
- Test type:
- standard acute method
- Limit test:
- yes
- Species:
- rat
- Strain:
- Sprague-Dawley
- Sex:
- male/female
- Details on test animals or test system and environmental conditions:
- TEST ANIMALS
- Source: Charles River (U.K.) Limited
- Age at study initiation: no data
- Weight at study initiation: mean weight for 284g males and 229g females.
- Fasting period before study: not applicable
- Housing: in suspended polypropylene cages with stainless steel grid tops and bottoms beneath which was a polypropylene tray containing absorbent paper.
- Diet (e.g. ad libitum): ad libitu, Special Diet Services Expanded Rat and Mouse Maintenance Diet No. 1 with known analysis
- Water (e.g. ad libitum): ad libitum
- Acclimation period: 8 days
ENVIRONMENTAL CONDITIONS
- Temperature (°C): 22 (21-24)
- Humidity (%): 37 (28-58)
- Air changes (per hr): no data
- Photoperiod (hrs dark / hrs light): no data
IN-LIFE DATES: no data - Type of coverage:
- occlusive
- Vehicle:
- unchanged (no vehicle)
- Details on dermal exposure:
- TEST SITE
- Area of exposure: the back of the animals
- % coverage: no data
- Type of wrap if used: The test material was placed on a piece of gauze which was then placed over the shaved skin and bound with Sleek occlusive tape.
REMOVAL OF TEST SUBSTANCE
- Washing (if done): the skin was wiped with a damp tissue to remove excess test material
- Time after start of exposure: 24h
TEST MATERIAL
- Amount(s) applied (volume or weight with unit): no data
- Concentration (if solution): no data - Duration of exposure:
- 24h
- Doses:
- 2000 mg/ kg bw
- No. of animals per sex per dose:
- 5
- Control animals:
- no
- Details on study design:
- - Duration of observation period following administration: 14 days
- Frequency of observations and weighing: daily observations and the animals were weighed at dosing after 7 days and at sacrifice
- Necropsy of survivors performed: yes - Statistics:
- not performed
- Sex:
- male/female
- Dose descriptor:
- LD50
- Effect level:
- > 2 000 mg/kg bw
- Remarks on result:
- other: no deaths
- Mortality:
- None
- Clinical signs:
- other: No clinical signs were noted at any stage of the test
- Gross pathology:
- No effects observed
- Interpretation of results:
- practically nontoxic
- Remarks:
- Migrated information Criteria used for interpretation of results: EU
- Conclusions:
- LD50 > 2000 mg/kb bw
- Executive summary:
The acute dermal toxicity of the test substance was investigated in male and female rats of the Sprague-Dawley strain. A single group of 5 male and 5 female rats was treated at a dose level of 2000 mg/kg bw. There were no deaths and no clinical signs were noted at any stage of the test. LD50 > 2000 mg/kg bw.
It is concluded that the test substance would not pose a hazard of percutaneous toxicity in normal use.
Reference
Endpoint conclusion
- Endpoint conclusion:
- no adverse effect observed
- Dose descriptor:
- LD50
- Value:
- 2 000 mg/kg bw
- Quality of whole database:
- Standard study according to OECD guideline, and following GLP principles.
Additional information
This substance, Tall oil + ammonia-ethanolamine reaction by-products (TO + AEA), differs from other substances in the AAI group that are based on fatty acids with polyamines, in that it contains a high amount of hydroxylated polyethylene amines, causing it to display more neutral OH groups, rather than basic primary amine groups. As toxicity is much related to the presence of free primary amine groups, it can be expected that in specifically in aspects of acute toxicity related to direct chemical interactions, this substance shows less effects compared to other AAI substances.
Tall oil + ammonia-ethanolamine reaction by-products was tested for acute oral toxicity in a standard acute oral toxicity according to OECD 401. The LD50 amounted to 4000 mg/kgbw. Animals dosed with levels up to 2250 mg/kg showed piloerection and hypokinesia up to three days, no mortality, and no findings at macroscopic evaluations. At higher dose levels mortality increased, with 100% mortality within one or two days at 6250 mg/kg.
All other studies with AAI substances show somewhat higher acute oral toxicity, but all with a LD50 > 2000 mg/kg bw. There is possibly a small tendency of decreased toxicity with increasing size of the EA.
Acute toxicity data on amidoamines/imidazolines (AAI):
TO + DETA >2000 mg/kg bw ,Cat.5; ATC cut off 2500mg/kg bw
TO + DETA >2000 mg/kg bw, Cat.5; ATC cut off 2500mg/kg bw
TO + TEPA >2000 mg/kg bw, Cat.5; ATC cut off 2500mg/kg bw
C16-18,C18 unsat+TEPA >2000 mg/kg bw, Cat.5; Limit test 20% mortality
TO + PolyAmidoamine >2000 mg/kg bw ,Cat.5; ATC cut off 5000mg/kg bw
TO + AEA 4000 mg/kg bw ,Cat.5
Acute dermal toxicity: A single group of 5 male and 5 female rats was treated at a dose level of 2000 mg/kg bw. There were no deaths and no clinical signs were noted at any stage of the test. LD50 > 2000 mg/kg bw.
Acute inhalation toxicity: Physical-chemical properties of Tall oil + ammonia-ethanolamine reaction by-products indicate a low likelihood for exposure via inhalation having a boiling point > 300 °C and a low vapour pressure (8.4 x 10 -8 Pa at 25°C).
Justification for selection of acute toxicity – oral endpoint
Only available study
Justification for selection of acute toxicity – inhalation endpoint
Likelihood of exposures via inhalation is low considering the high boiling point (> 300 °C) and very low vapour pressure (8.4 x 10-8 Pa at 25°C for this substance).
Justification for selection of acute toxicity – dermal endpoint
Only available study
Justification for classification or non-classification
Acute oral exposure of Tall oil + ammonia-ethanolamine reaction by-products show limited acute toxicity, with a LD50 above 2000 mg/kg bw via oral as well as dermal route. Hence no classification is required.
For acute inhalation toxicity information for classification is lacking, but is testing not justified. Due to very low vapour pressure is the likelihood of exposure low.
AAI do not contain containing aliphatic, alicyclic and aromatic hydrocarbons and have a relatively high viscosity and so do not indicate an immediate concern for aspiration hazard.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.
![ECHA](/o/diss-blank-theme/images/factsheets/A-REACH/factsheet/echa_logo.png)